T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for T2 BIOSYSTEMS INC by T2 Biosystems, Inc. (TTOO).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Hold

Consensus RatingHold# Analysts1Avg. Consensus PT$5Upside to Avg. PT+833233.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 30, 2024	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$3→$5
Apr 29, 2024	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$12→$3

Analyst Ratings News

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and raises the price target from $3 to $5.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and lowers the price target from $12 to $3.

Benzinga Newsdesk

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $0.07

Alliance Global Partners analyst Ben Haynor maintains T2 Biosystems (NASDAQ:TTOO) with a Neutral and lowers the price target from $0.12 to $0.07.

Benzinga Newsdesk

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Alliance Global Partners analyst Ben Haynor maintains T2 Biosystems (NASDAQ:TTOO) with a Neutral and lowers the price target from $2.2 to $1.5.

Benzinga Newsdesk

Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%

Wells Fargo cut the price target on Tesla, Inc. (NASDAQ: TSLA) from $280 to $230. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating on the stock. Tesla shares fell 0.4% to $220.85 in pre-market trading.

Lisa Levin

PRO
Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.

Benzinga Newsdesk

T2 BIOSYSTEMS INC by T2 Biosystems, Inc.

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $0.07

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%

PRO
Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

T2 BIOSYSTEMS INC by T2 Biosystems, Inc.

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5

PROCanaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

PROAlliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $0.07

PROAlliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80%

PROCanaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Raises Price Target to $5

PRO
Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $0.07

PRO
Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

PRO
Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5